68.14
price up icon3.35%   2.21
after-market Dopo l'orario di chiusura: 68.25 0.11 +0.16%
loading
Precedente Chiudi:
$65.93
Aprire:
$67.055
Volume 24 ore:
1.38M
Relative Volume:
0.48
Capitalizzazione di mercato:
$5.88B
Reddito:
$170.10M
Utile/perdita netta:
$-239.59M
Rapporto P/E:
-24.34
EPS:
-2.8
Flusso di cassa netto:
$-191.20M
1 W Prestazione:
+23.58%
1M Prestazione:
+49.59%
6M Prestazione:
+54.06%
1 anno Prestazione:
+19.15%
Intervallo 1D:
Value
$67.01
$68.72
Intervallo di 1 settimana:
Value
$54.80
$71.13
Portata 52W:
Value
$30.04
$71.13

Crispr Therapeutics Ag Stock (CRSP) Company Profile

Name
Nome
Crispr Therapeutics Ag
Name
Telefono
(617) 315-4600
Name
Indirizzo
BAARERSTRASSE 14, ZUG
Name
Dipendente
393
Name
Cinguettio
@crisprtx
Name
Prossima data di guadagno
2024-12-05
Name
Ultimi documenti SEC
Name
CRSP's Discussions on Twitter

Confronta CRSP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CRSP
Crispr Therapeutics Ag
68.14 5.69B 170.10M -239.59M -191.20M -2.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Crispr Therapeutics Ag Stock (CRSP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-14 Aggiornamento Evercore ISI In-line → Outperform
2025-02-12 Aggiornamento TD Cowen Sell → Hold
2025-02-03 Iniziato H.C. Wainwright Buy
2024-08-06 Reiterato Needham Buy
2024-08-02 Iniziato Rodman & Renshaw Buy
2024-06-28 Ripresa Guggenheim Neutral
2024-02-15 Iniziato Wolfe Research Peer Perform
2023-12-11 Downgrade TD Cowen Market Perform → Underperform
2023-10-17 Downgrade Cantor Fitzgerald Overweight → Neutral
2023-09-27 Iniziato Mizuho Buy
2023-08-17 Aggiornamento Citigroup Neutral → Buy
2023-05-30 Iniziato William Blair Outperform
2023-04-13 Iniziato Cantor Fitzgerald Overweight
2023-03-21 Iniziato Bernstein Mkt Perform
2023-03-17 Iniziato Bryan Garnier Buy
2023-03-07 Iniziato Robert W. Baird Neutral
2022-10-11 Iniziato Morgan Stanley Underweight
2022-08-09 Downgrade Barclays Overweight → Equal Weight
2022-06-23 Downgrade Evercore ISI Outperform → In-line
2022-06-17 Iniziato BMO Capital Markets Outperform
2022-04-28 Iniziato Credit Suisse Neutral
2021-12-07 Iniziato Cowen Market Perform
2021-10-19 Iniziato SVB Leerink Outperform
2021-06-14 Aggiornamento Citigroup Sell → Neutral
2021-04-21 Aggiornamento Jefferies Hold → Buy
2021-03-04 Iniziato JMP Securities Mkt Outperform
2020-12-10 Reiterato Chardan Capital Markets Buy
2020-12-10 Downgrade Jefferies Buy → Hold
2020-12-10 Reiterato Needham Buy
2020-12-07 Downgrade Wells Fargo Overweight → Equal Weight
2020-10-23 Iniziato RBC Capital Mkts Sector Perform
2020-10-05 Iniziato BofA Securities Buy
2020-07-28 Reiterato Needham Buy
2020-07-14 Iniziato SunTrust Buy
2020-06-15 Reiterato Canaccord Genuity Buy
2020-03-05 Iniziato Stifel Hold
2020-02-03 Downgrade Evercore ISI Outperform → In-line
2019-11-19 Aggiornamento William Blair Mkt Perform → Outperform
2019-11-12 Aggiornamento Oppenheimer Perform → Outperform
2019-08-01 Iniziato Jefferies Buy
2019-07-26 Iniziato Canaccord Genuity Buy
2019-06-10 Iniziato ROTH Capital Buy
2019-04-12 Iniziato Evercore ISI Outperform
2019-03-14 Iniziato William Blair Mkt Perform
2019-01-28 Downgrade Goldman Buy → Neutral
2019-01-22 Downgrade Citigroup Neutral → Sell
Mostra tutto

Crispr Therapeutics Ag Borsa (CRSP) Ultime notizie

pulisher
Jul 23, 2025

Is CRISPR Therapeutics AG a good long term investmentRemarkably fast returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

CRISPR Therapeutics AG Stock Analysis and ForecastOutperformance with explosive growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

CRISPR Therapeutics (CRSP) Surges 71% Last Quarter With Inclusion In Russell Indices - simplywall.st

Jul 23, 2025
pulisher
Jul 23, 2025

Crispr Therapeutics: Shares Are SoaringThis Could Be The Start Of Something Big (CRSP) - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

What drives CRISPR Therapeutics AG stock priceExceptional trading results - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Private Advisor Group LLC Increases Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Jul 23, 2025
pulisher
Jul 22, 2025

Research Analysts Set Expectations for CRSP Q2 Earnings - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Bank of America Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $78.00 - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Crispr Therapeutics price target lowered to $78 from $79 at BofA - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about CRISPR Therapeutics AG stockDynamic profit expansion - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

CRISPR Therapeutics' Stock Surge: A Glimpse into the Future of Gene-Editing Investment - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat

Jul 21, 2025
pulisher
Jul 21, 2025

CRISPR Therapeutics Rises Amid Gene Editing Breakthroughs - StocksToTrade

Jul 21, 2025
pulisher
Jul 21, 2025

CRISPR Stock (CRSP) Continues to Sizzle on Insider Deal - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

Insider Buying: CRISPR Therapeutics AG (NASDAQ:CRSP) Director Buys 989,812 Shares of Stock - MarketBeat

Jul 21, 2025
pulisher
Jul 21, 2025

3 Monster Stocks in the Making to Buy Right Now - The Motley Fool

Jul 21, 2025
pulisher
Jul 20, 2025

CRISPR Therapeutics (CRSP) Soars 18% After $51-Million Insider Trading - MSN

Jul 20, 2025
pulisher
Jul 19, 2025

Q2 EPS Estimate for CRISPR Therapeutics Lifted by Analyst - MarketBeat

Jul 19, 2025
pulisher
Jul 19, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $71.75 Average Price Target from Analysts - MarketBeat

Jul 19, 2025
pulisher
Jul 19, 2025

Crispr Therapeutics AG Stock Soars Amid Insider Confidence - TipRanks

Jul 19, 2025
pulisher
Jul 19, 2025

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

Is It Worth Investing in CRISPR Therapeutics (CRSP) Based on Wall Street's Bullish Views? - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 5.7%What's Next? - MarketBeat

Jul 18, 2025
pulisher
Jul 18, 2025

CRSP’s Astounding Gains: Should Investors Jump In? - timothysykes.com

Jul 18, 2025
pulisher
Jul 18, 2025

CRISPR Therapeutics (CRSP) Surges after Director Buys over $51M Worth of Shares - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Crispr stock soars after director buys $51.5 million in shares - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

CRISPR Therapeutics Breaks Ground with Promising Phase 1 Trial Advances - timothysykes.com

Jul 18, 2025
pulisher
Jul 18, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Hits New 52-Week High Following Insider Buying Activity - MarketBeat

Jul 18, 2025
pulisher
Jul 18, 2025

Crispr director George buys $51.5M of shares (CRSP:NASDAQ) - Seeking Alpha

Jul 18, 2025
pulisher
Jul 18, 2025

Crispr Therapeutics stock hits 52-week high at 62.32 USD - Investing.com

Jul 18, 2025
pulisher
Jul 17, 2025

Director Makes Multi-Million Dollar Investment in Crispr Therapeutics AG! - TipRanks

Jul 17, 2025

Crispr Therapeutics Ag Azioni (CRSP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):